Synergistic effects of agouti protein and rosiglitazone on bone loss in a murine model of obesity and type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [21] Rosiglitazone increases hippocampal neurogenesis in type 2 diabetes animal model
    Jeong, S. W.
    Choi, E.
    Noh, J. H.
    Kim, D. W.
    JOURNAL OF NEUROLOGY, 2007, 254 : 109 - 109
  • [22] The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
    Tan, GD
    Fielding, BA
    Currie, JM
    Humphreys, SM
    Désage, M
    Frayn, K
    Laville, M
    Vidal, H
    Karpe, F
    DIABETOLOGIA, 2005, 48 (01) : 83 - 95
  • [23] Combined effects of rosiglitazone and atorvastatin on the dyslipidaemia associated with Type 2 diabetes
    Stewart, M
    Jones, NP
    Kreider, M
    Cohen, B
    Freed, M
    Biswas, N
    Rattner, R
    Brunzell, J
    DIABETOLOGIA, 2001, 44 : A222 - A222
  • [24] The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
    G. D. Tan
    B. A. Fielding
    J. M. Currie
    S. M. Humphreys
    M. Désage
    K. N. Frayn
    M. Laville
    H. Vidal
    F. Karpe
    Diabetologia, 2005, 48 : 83 - 95
  • [25] Obesity, type 2 diabetes and weight loss in African American women with type 2 diabetes.
    Lieberman, LS
    Probart, CK
    Schoenberg, NE
    AMERICAN JOURNAL OF HUMAN BIOLOGY, 1999, 11 (01) : 119 - 119
  • [26] Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
    Pereira, Marie
    Gohin, Stephanie
    Roux, Jean-Paul
    Fisher, Amy
    Cleasby, Mark E.
    Mabilleau, Guillaume
    Chenu, Chantal
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [27] Obesity and type 2 diabetes adversely affect bone health
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2016, 18 (01): : 111 - 111
  • [28] Weight loss and side-effects of liraglutide and lixisenatide in obesity and type 2 diabetes mellitus
    Lee, Jeongmin
    Kim, Raeun
    Kim, Min-Hee
    Lee, Seung-Hwan
    Cho, Jae-Hyoung
    Lee, Jung Min
    Jang, Sang-Ah
    Kim, Hun-Sung
    PRIMARY CARE DIABETES, 2023, 17 (05) : 460 - 465
  • [29] Compares effects of Glimepiride and Rosiglitazone on dysglycemia and oxidative stress of type 2 diabetes
    Monnier, L.
    Colette, C.
    Boegner, C.
    Michel, F.
    Nachbaur, G.
    Comenducci, A.
    DIABETES & METABOLISM, 2009, 35 : A60 - A60
  • [30] Differential rosiglitazone effects on cardiovascular diseases in VA type 2 diabetes patients
    Wang, Chenpin
    Haffner, Steve
    Defronzo, Ralph
    Pugh, Jacqueline
    DIABETES, 2008, 57 : A179 - A179
12345